Recently, our group observed endogenous T-cell recognition of the ETV6::RUNX1 fusion neoantigen in patients with ALL, which is the most common genetic aberration in childhood ALL, occurring in approximately 25% of patients [15, 16]. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.